Citadel Advisors »

Crescent Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $304k 26k 11.89

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Crescent Biopharma

FMR
Fairmount Funds Management
VR Adviser
BVF
Tang Capital Management
Vanguard Group
Logos Global Management
Deep Track Capital
Boxer Capital Management
Perceptive Advisors
Commodore Capital
Driehaus Capital Management
Frazier Life Sciences Management
Adage Capital Partners GP
Soleus Capital Management

View all funds holding Crescent Biopharma